Capricor Therapeutics | CAPR - Gross Profit On Sales


Capricor Therapeutics reported 11.13M in Gross Profit on Sales for its fiscal quarter ending in December of 2024.





Gross Profit On Sales Change Date
Bioline Rx USD 343K 111K Sep/2025
Capricor Therapeutics 11.13M 8.87M Dec/2024
Cipla INR 39.1B 2.54B Mar/2026
Cytokinetics USD 19.2M 1.44M Mar/2026
Geron USD 50.14M 3.44M Mar/2026
Grifols EUR 766.49M 39.74M Dec/2024
Immunic 0 0 Mar/2025
J&J USD 17.24B 642M Mar/2026
Plus Therapeutics 1.37M 30K Dec/2025
Prothena USD 21K 2.39M Dec/2025
PTC Therapeutics USD 232.94M 84.56M Mar/2026
Sarepta Therapeutics USD 621.34M 577.79M Mar/2026